Skip to main content

Table 4 Categorization of hematologic abnormalities

From: Significance of hematologic abnormalities in COVID-19 severity among infected patients in Lagos, Nigeria

 

NSCP (n = 165)

SCP (n = 71)

n

%

n

%

Hb (g/dL)

    

Anemia (< 11)

9

5.5

13

18.3

Normal (11–16)

126

76.4

56

78.9

Polycythemia (> 16)

30

18.2

2

2.8

P value (< 0.05)

< 0.001

RBC (x/L)

    

Anemia (< 3.5)

3

1.8

8

11.3

Normal (3.5–5.5)

124

75.2

55

77.5

Polycythemia (> 5.5)

38

23.0

8

11.3

P value (< 0.05)

< 0.001

PCV (%)

    

Anemia (< 37)

40

24.2

30

42.3

Normal (37–54)

123

74.5

41

57.7

Polycythemia (> 54)

2

1.2

0

0.0

P value (< 0.05)

0.016

WBC (x/L)

    

Leukopenia (< 4)

22

13.3

3

4.2

Normal (4–10)

122

73.9

41

57.7

Leukocytosis (> 10)

21

12.7

27

38.0

P value (< 0.05)

< 0.001

Neu (%)

    

Neutropenia (< 50)

45

27.3

9

12.7

Normal (50–70)

81

49.1

16

22.5

Neutrophilia (> 70)

39

23.6

46

64.8

P value (< 0.05)

< 0.001

Lym (%)

    

Lymphocytopenia (< 20)

26

15.8

43

60.6

Normal (20–40)

91

55.2

21

29.6

Lymphocytosis (> 40)

48

29.1

7

4.2

P value (< 0.05)

< 0.001

PLT (x/L)

    

Thrombocytopenia (< 100)

1

0.6

2

2.8

Normal (100–300)

142

86.1

54

76.1

Thrombocytosis (> 300)

22

13.3

15

21.1

P value (< 0.05)

0.109

  1. SCP (severe patients with COVID-19); NSCP (non-severe patients with COVID-19); Hb (hemoglobin); RBC (red blood cell); PCV (packed cell volume); MCV (mean corpuscular volume); MCH (mean corpuscular hemoglobin); MCHC (mean corpuscular hemoglobin concentration); WBC (white blood cell); Neu (neutrophils); MID (mid-range absolute); Lym (lymphocytes); PLT (platelet). The P value represents a comparison of the SCP and NSCP groups for each hematologic parameter, which consisted of patients with low, normal, and high values in each group. “Normal” refers to patients with values within the parameter reference ranges